Black Americans are 3–4 times more likely to develop nondiabetic kidney disease than other populations (Laster et al. 2018), and exonic risk variants in Apolipoprotein L1 (APOL1) drive much of this increased susceptibility. Here, APOL1 is linked to kidney disorder.